Biden’s FDA Commissioner Playbook: Build On COVID Innovations To Modernize Agency

 
• By Nancy Bradish Myers

Unintended silver lining of pandemic-generated innovation has brought the agency to an opportunistic fork in the road, and the commissioner choice will be consequential in determining the path forward.

Biden post-election
Incoming president can choose a commissioner who can seize the opportunity to leverage the agency’s COVID innovations to meet the challenges of 21st century health care. • Source: Alex Gakos for Shutterstock

More from US FDA

More from Agency Leadership